Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of HSK44459 in adults with Behcet's disease
CTR20250829Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK44459 in Behçet's disease (BD), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Apr 2025; status: active.
02
Drugs
HSK44459
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on CTR20250829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250829.